Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 64,359 | 6,291 | 8,360 | 4,007 | 101 |
| Cost of Goods | 36,892 | 2,259 | 2,837 | 2,126 | N/A |
| Gross Profit | 27,467 | 4,032 | 5,523 | 1,881 | 101 |
| Operating Expenses | 92,043 | 47,492 | 45,691 | 53,979 | 30,644 |
| Operating Income | -63,684 | -43,201 | -39,331 | -51,972 | -30,543 |
| Interest Expense | 12,759 | 438 | 167 | 77 | 375 |
| Other Income | 270 | 1,335 | 678 | 6,505 | 1,548 |
| Pre-tax Income | -76,173 | -42,304 | -38,820 | -45,544 | -29,370 |
| Net Income Continuous | -76,173 | -42,304 | -38,820 | -45,544 | -29,370 |
| Net Income | $-76,173 | $-42,304 | $-38,820 | $-45,544 | $-29,370 |
| EPS Basic Total Ops | -2,100.00 | -1,400.00 | -1,700.00 | -2,600.00 | -2,290.00 |
| EPS Basic Continuous Ops | -2,091.08 | -1,424.75 | -1,679.07 | -2,579.24 | -2,285.35 |
| EPS Diluted Total Ops | -2,100.00 | -1,400.00 | -1,700.00 | -2,600.00 | -2,290.00 |
| EPS Diluted Continuous Ops | -2,091.08 | -1,424.75 | -1,679.07 | -2,579.24 | -2,285.35 |
| EPS Diluted Before Non-Recurring Items | -2,100.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-61,974 | $-42,204 | $-39,241 | $-51,891 | $-30,499 |